Outcomes of Patients With MCI With Lewy Bodies or Alzheimer Disease

Dr. Calum Alexander Hamilton, an expert on managing mild cognitive impairment (MCI), joins Dr. Jeff Ratliff, who specializes in outcomes for Lewy body pathology. They delve into the critical importance of monitoring patients with MCI, particularly those at risk of progressing to dementia. The conversation highlights alarming rates of dementia development among these individuals, comparing the timelines for Lewy bodies versus Alzheimer’s disease. They also stress the vital role of brain tissue donation in enhancing diagnostic accuracy and understanding of dementia subtypes.